Alzheimer’s disease, the most common type of dementia, is famously characterized by the heavy accumulation of amyloid plaques in the brain: but how can researchers determine the impact of these plaques on the cellular microenvironment?
In a new application note, we dug deep into this question using our Xenium In Situ technology to conduct a large-scale analysis in a mouse model of Alzheimer's disease. Sign up to download your copy and discover how this cutting-edge technology: